cyclohexylalanine has been researched along with Blood Clot in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Appleby, SD; Baskin, EP; Chen, IW; Dancheck, KB; Gardell, SJ; Lewis, SD; Lucas, BJ; Lumma, WC; Lyle, EA; Lynch, JJ; Tucker, TJ; Vacca, JP; Woltmann, R | 1 |
1 other study(ies) available for cyclohexylalanine and Blood Clot
Article | Year |
---|---|
Potent noncovalent thrombin inhibitors that utilize the unique amino acid D-dicyclohexylalanine in the P3 position. Implications on oral bioavailability and antithrombotic efficacy.
Topics: Animals; Biological Availability; Dipeptides; Dogs; Fibrinolytic Agents; Lipid Metabolism; Male; Molecular Structure; Partial Thromboplastin Time; Phenylalanine; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thrombin; Thrombosis | 1997 |